SCOPE International AG is pleased to announce the appointment of Adam Braithwaite as the key contact for Business Development in the US. Adam will join the SCOPE BD team as part of its North American subsidiary, SCOPE International USA, based in Pittsburgh, PA. In his new position, he will support our clients for their ongoing needs and will support the development of future products together with our customers.

“We are pleased to welcome Adam Braithwaite as our new team member in Business Development to facilitate SCOPE’s local activities for our clients in the USA and Canada,”

– says Dr. Christoph Franz, Head of Business Development at SCOPE International AG

Adam has worked for SCOPE in clinical operations since the start of the US business where he gained a first-hand understanding of clinical operations and regulatory affairs services which will allow him to be a competent contact for our US and Canada partners. SCOPE’s USA office was opened in 2015 and has continuously grown while supporting numerous sponsors through clinical trials in both the USA and Canada. Adam’s transition into the business development role comes at a strategic time as the office is in an excellent position and is primed to continue to grow.

“I truly believe that SCOPE’s quality, flexibility, and commitment has created a culture that sets us apart from other CROs. I look forward to continuing to work with our existing clients and to creating new relationships with other pharmaceutical and biotechnical companies with needs that SCOPE is able to meet.“

– says Adam Braithwaite